Doubek M - Search Results

1

Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.

Greil R, Obrtlíková P, Smolej L, Kozák T, Steurer M, Andel J, Burgstaller S, Mikušková E, Gercheva L, Nösslinger T, Papajík T, Ladická M, Girschikofsky M, Hrubiško M, Jäger U, Fridrik M, Pecherstorfer M, Králiková E, Burcoveanu C, Spasov E, Petzer A, Mihaylov G, Raynov J, Oexle H, Zabernigg A, Flochová E, Palášthy S, Stehlíková O, Doubek M, Altenhofer P, Pleyer L, Melchardt T, Klingler A, Mayer J, Egle A. Greil R, et al. Among authors: doubek m. Lancet Haematol. 2016 Jul;3(7):e317-29. doi: 10.1016/S2352-3026(16)30045-X. Epub 2016 Jun 16. Lancet Haematol. 2016. PMID: 27374465 Clinical Trial.

2

[Autologous transplantation of peripheral hematopoietic cells in a patient with multiple myeloma and renal insufficiency].

Krejcí M, Doubek M, Adam Z, Hájek R, Vorlícek J, Mayer J. Krejcí M, et al. Among authors: doubek m. Vnitr Lek. 1997 Nov;43(11):756-8. Vnitr Lek. 1997. PMID: 9650509 Czech.

3

[Must we be really concerned about amphotericin B toxicity in oncology patients?].

Mayer J, Doubek M. Mayer J, et al. Among authors: doubek m. Cas Lek Cesk. 1998 Oct 19;137(20):632-6. Cas Lek Cesk. 1998. PMID: 9863267 Czech.

4

Must we really fear toxicity of conventional amphotericin B in oncological patients?

Mayer J, Doubek M, Vorlìcek J. Mayer J, et al. Among authors: doubek m. Support Care Cancer. 1999 Jan;7(1):51-5. doi: 10.1007/s005200050224. Support Care Cancer. 1999. PMID: 9926976

5

Ifosfamide- and etoposide-based chemotherapy as salvage and mobilizing regimens for poor prognosis lymphoma.

Mayer J, Vásová I, Korístek Z, Navrátil M, Klabusay M, Doubek M, Vorlícek J, Cernilová I, Vodvárka P, Petráková K. Mayer J, et al. Among authors: doubek m. Eur J Haematol Suppl. 2001 Jul;64:21-7. Eur J Haematol Suppl. 2001. PMID: 11486396 Clinical Trial.

6

[Safety of long-term administration of conventional amphotericin B in oncology patients].

Doubek M, Mayer J, Horký D. Doubek M, et al. Cas Lek Cesk. 2002 Mar;141(5):156-9. Cas Lek Cesk. 2002. PMID: 11998223 Czech.

7

Reduced-intensity allografting for chronic myeloid leukemia in the first chronic phase.

Doubek M, Vitek A, Mayer J. Doubek M, et al. Haematologica. 2004 Apr;89(4):ELT03. Haematologica. 2004. PMID: 15075116 No abstract available.

8

Pulse cyclophosphamide for corticosteroid-refractory graft-versus-host disease.

Mayer J, Krejcí M, Doubek M, Pospísil Z, Brychtová Y, Tomíska M, Rácil Z. Mayer J, et al. Among authors: doubek m. Bone Marrow Transplant. 2005 Apr;35(7):699-705. doi: 10.1038/sj.bmt.1704829. Bone Marrow Transplant. 2005. PMID: 15696180

9

Idiopathic systemic capillary leak syndrome misdiagnosed and treated as polycythemia vera.

Doubek M, Brychtova Y, Tomiska M, Mayer J. Doubek M, et al. Acta Haematol. 2005;113(2):150-1. doi: 10.1159/000083455. Acta Haematol. 2005. PMID: 15802896 No abstract available.

10

Mycophenolate mofetil for the treatment of acute and chronic steroid-refractory graft-versus-host disease.

Krejci M, Doubek M, Buchler T, Brychtova Y, Vorlicek J, Mayer J. Krejci M, et al. Among authors: doubek m. Ann Hematol. 2005 Oct;84(10):681-5. doi: 10.1007/s00277-005-1070-0. Epub 2005 Jul 7. Ann Hematol. 2005. PMID: 16001244

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters